english | 中 文   
点击发送消息给对方   点击发送消息给对方 
[email protected]
对不起, 暂时还没有相关信息
Sichuan Credit Chemwerth Pharmaceutical Co., Ltd (Credit-Chemwerth) was founded in 2007. It is specializing in researching, developing and manufacturing APIs and intermediates. The company had acquired China GMP certificate (2010 version), and passed US FDA inspection in 2010, 2012 and 2015.
Credit-Chemwerth is a Sino-US joint venture company established by Sichuan Credit Pharmaceutical Co., Ltd (China) and Chemwerth Inc. (US). The company not only provides APIs for holding companies, but also provides intermediates and APIs for both domestic and international pharmaceutical companies.
 The products mainly are sold in domestics market as well as in EU and USA. The company is engaging in developing on new market, e.g. Japan, Korea, Middle East, South America, etc.
Vecuronium Bromide (hit: 900)
Tizanidine Hydrochloride (hit: 903)
Valproate Sodium (hit: 950)
Pipecuronium Bromide (hit: 879)
Epinastine Hydrochloride (hit: 895)
Busulfan (hit: 874)
Tiagabine Hydrochloride (hit: 855)
Temozolomide (hit: 838)
Topotecan Hydrochloride (hit: 856)
Melphalan/ Melphalan Hydrochloride (hit: 827)
 contact | add favorites | set home copyright chemwerth © all rights reserved 蜀icp备08108828号 design by:vansn 
 您是本站第 位访客  
上证指数多少买入好 手机篮球比分器 1990至2018上证指数 青海快三 极速时时彩 买股票指数买多少股好 时时彩 股票配资平台是合法的么 第一策略配资 阿里巴巴股票行情走势 海南飞鱼 互联网理财平台的优势 山东时时彩 智富配资 股票配资平台代理怎么拿 多乐彩